Market Inference Overview -- AME Stock

By Tamara Parker • Tuesday, December 12 16:42 • Permanent Link

Large-cap Industrials company AMETEK has moved 2.3% so far today on a volume of 1,091,156, compared to its average of 1,049,577. In contrast, the S&P 500 index moved 0.0%.

AMETEK trades -6.28% away from its average analyst target price of $172.15 per share. The 13 analysts following the stock have set target prices ranging from $154.0 to $195.0, and on average have given AMETEK a rating of buy.

Anyone interested in buying AME should be aware of the facts below:

AMETEK's current price is 140.1% above its Graham number of $67.19, which implies that at its current valuation it does not offer a margin of safety
AMETEK has moved 10.0% over the last year, and the S&P 500 logged a change of 15.0%
Based on its trailing earnings per share of 5.52, AMETEK has a trailing 12 month Price to Earnings (P/E) ratio of 29.2 while the S&P 500 average is 15.97
AME has a forward P/E ratio of 23.9 based on its forward 12 month price to earnings (EPS) of $6.76 per share
The company has a price to earnings growth (PEG) ratio of 2.46 — a number near or below 1 signifying that AMETEK is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 4.46 compared to its sector average of 4.06
AMETEK, Inc. manufactures and sells electronic instruments and electromechanical devices in North America, Europe, Asia, and South America.
Based in Berwyn, the company has 19,600 full time employees and a market cap of $37.24 Billion. AMETEK currently returns an annual dividend yield of 0.6%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.